About Us

Shalabh has more than 30 years of experience, mostly as a consultant in the life sciences industry. Past roles include strategy consultant at Accenture in London and later adviser to the Global R&D services group; co-founder, COO and then CEO of Kinapse, a life sciences consulting and outsourcing company which was acquired by Syneos Health, a leading CRO; global head of services at Navitas, a life sciences consulting and services company. He now works as an independent consultant and investor in the life sciences industry, working with biopharma companies, CROs, PE firms and start-ups. Over a long consulting career, he has worked with many of the leading pharmaceutical companies as well many CROs and services companies.

Shalabh is a co-founder of Pharmalancers, the parent company of AvisenRX.

Shanaka (Shani) is an experienced life sciences advisor with a proven record of success leading teams and managing complex international projects across R&D: Medical, Clinical, Regulatory, and Safety. He draws from over 15 years’ experience spanning a spectrum of business capabilities, including strategy, governance, quality oversight, organisational design, and process optimisation. As an independent consultant, he has worked with a range of R&D functions at biopharma organisations in Europe and the US; prior to this Shanaka has worked at a range of consulting firms including Accenture, EY, PwC, and Syneos Health.

Angela has over 30 years’ experience working in the pharmaceutical and life sciences professional service and outsourcing sector. She has held strategic, commercial and operational leadership positions in entrepreneurial, fast-pace and rapid-growth organisations, based in the EU, US and India. During her career she has been a senior executive in Innovex (IQVIA), Covance (LabCore) and Kinapse (Syneos Health) all successful BPOs servicing the Pharmaceutical and Life Sciences sector. She has an established track record in driving effective organic business growth through her strong people and commercial leadership abilities.

Angela is a co-founder of Pharmalancers, the parent company of AvisenRX.

Adrian is a graduate of Loughborough University, with a bachelor's degree in Chemistry & Sports Science and a master's degree in Analytical Chemistry and Instrumentation. Adrian has over 20 years of experience in the scientific development and project management fields, is a member of the Pharmaceutical Industry Project Management Group, and is PRINCE2 practitioner trained. He has been pivotal in embedding world leading project management methodologies into multiple life science organisations and specialises in delivering project management and continuous improvement leadership within complex development programs and teams.

Thunicia’s career in Life Sciences spans more than 20 years, encompassing scientific research, pharmaceutical sales, competitive intelligence, bespoke market research, with 14 years in pharmaceutical and biotech consulting focused on New Product Planning and Commercialisation, at Deallus, Navigant, and Syneos Health. Most recently, as Asset Strategy Lead, she co-led a joint cross-functional integrated development team, driving the long-term asset roadmap and overseeing operational execution. Thunicia has experience across multiple therapy areas, primarily rare diseases and immunology, with an academic background in respiratory. She has been a trusted advisor to partners at emerging biotechs, small, mid-sized and large pharmaceutical companies.

Rob has deep expertise in strategic planning and execution in the late-stage oncology drug development field: “Delivering innovative medicines from breakthrough science.” A key theme in Rob’s career has been his involvement in biomarker led therapies. Over the last 17 years he has been at the forefront of embedding diagnostics in clinical development programs and evolving commercial testing to support patient access to novel medicines. His experience spans working at AstraZeneca, MerckSerono and Janssen. Rob appreciates the importance of organisational design, complementarity within teams and leadership, to optimise outcomes.

Having been an avid sportsman all his life Rob regularly undertakes major sporting challenges to support charity fund raising.

Dale has over 23 year's experience in commercial roles in Life Sciences Businesses. He has worked to a global level both operationally and strategically. He spent 13 years at Orion Pharma before successfully building the Commercial operations at Ridge Pharma, a PE backed start-up branded generic organisation. Dale has an end to end understanding of commercial business needs.
Dale advises organisations and delivers on projects through disciplined planning and project management, rapidly understanding project needs. He delivers concise and clear outputs to give clarity to your business decisions. His energetic, but relaxed style, means that he creates a fun and enjoyable atmosphere to the projects he works on.

Alan has 25+ years experience in senior medical affairs in biotechnology. A biochemist, he undertook his post-doctoral research at Johns Hopkins Medical School, Baltimore. As VP Medical Affairs at Circassia he directed the successful introduction of novel diagnostic devices to healthcare providers in the UK and Europe. As Medical Affairs Director at IQVIA he also sat on the Strategic Market Access group in rare diseases and precision medicine in oncology.

Alan advises on Medical Affairs and Market Access, focusing on inter-functional synergy to optimise bringing novel products to markets. He has a passion for innovating this process for medical devices.

Mel is a senior advisor to life science companies with a passion for enabling access to innovation. He focusses on helping companies enhance their potential for global launch, partnering or acquisition by integrating commercial and market access perspectives at an early stage of R&D.

Mel spent over two decades in the pharmaceutical industry in early and late phase commercial and access roles. He has held leadership positions at Roche, GSK and Otsuka and launched multiple products across UK, European and Global markets. Mel was a senior executive for ten years, sitting on global R&D, business development, digital health, and corporate strategy boards.

Elizabeth is an accomplished leader in Global Programme & Project Management for Clinical Development. She has over thirty years of experience in clinical strategy and operations delivery on a global scale. With a strong foundation in pharmaceutical, medical device and biotech industries, she has deep knowledge of clinical development spanning different modalities and therapeutic areas, from Phase I to IV. Having resided and worked in key global markets such as the UK, Germany, Japan, and Australia, she has honed her skills in fostering international collaborations and overseeing projects within intricate logistical environments.
Elizabeth has managed substantial long-term contracts with key partners such as Archimedes, Crucell / J&J, Fourteen22 / Epirus, Sanofi Aventis and UCB. Additionally, she has worked on numerous short-term contracts for specific project engagements, collaborating with a diverse range of organizations.